Inactive Instrument

Highlights Pardes Biosciences, Inc.

Equities

PRDS

US69945Q1058

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

MediPacific, Inc. completed the acquisition of Pardes Biosciences, Inc. from a group of shareholders.	23-08-30	CI
Pardes Biosciences Receives Tender Offer for MediPacific Merger Deal	23-08-28	MT
Pardes Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-04	CI
Pardes Biosciences Agrees to Be Acquired by MediPacific; Shares Rise	23-07-17	MT
Pardes Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-05	CI
Pardes Biosciences to suspend COVID-19 drug development after mid-stage trial fails	23-04-03	RE
Pardes Biosciences, Inc. Announces Top-Line Results from Phase 2 Trial Evaluating Pomotrelvir for the Treatment of Covid-19	23-04-03	CI
Pardes Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
Pardes Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-14	CI
Pardes Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-14	CI
RM LAW Announces Investigation of Pardes Biosciences, Inc.	23-01-30	PR
Pardes Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07	CI
Pardes Biosciences, Inc. Announces Commencement of Phase 2 Trial Evaluating PBI-0451 for the Treatment of SARS-CoV-2 Infections	22-09-13	CI
Pardes Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Pardes Biosciences, Inc. Provides Updates on PBI-0451 Program	22-06-09	CI
Earnings Flash (PRDS) PARDES BIOSCIENCES Reports Q1 Loss $-0.38	22-05-10	MT
Pardes Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-10	CI
Pardes Biosciences : Reports Full Year 2021 Financial Results and Provides Business Update - Form 8-K	22-03-29	PU
Pardes Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-29	CI
Pardes Biosciences Reports Full Year 2021 Financial Results and Provides Business Update	22-03-29	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pardes Biosciences, Inc.

Equities

PRDS

US69945Q1058

Highlights

Filters